Observational studyThe Korean journal of internal medicine2021

A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea.

Jaemin Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.